Barely a mile from where an SUV packed with 25 people struck a tractor-trailer — killing 13 inside — a cemetery with unmarked bricks is a burial ground for migrants who died crossing the border from Mexico to remote California desert.
Barely a mile from where an SUV packed with 25 people struck a tractor-trailer — killing 13 inside — a cemetery with unmarked bricks is a burial ground for migrants who died crossing the border from Mexico to remote California desert.
The Panevezys Regional Court by the ruling dated 20 April 2021 in the case of payment of the interest calculated by the Competition Council of the Republic of Lithuania for the whole period of judicial proceedings when the Company litigated the fine imposed on the Company by the Competition Council has left the court ruling by the Panevezys Chamber of the Panevezys District Court unaffected. The Company is reviewing the motives set out in the court ruling and will make the decision on appealing to the Supreme Court of Lithuania in the nearest future. In the opinion of the Company, even after the ruling by the Panevezys Regional Court there are ambiguities remaining in respect of practical application of the rules for interest calculation provided for in the Law on Competition of the Republic of Lithuania. Therefore, the Company thinks that the position of the Court of Cassation in this case would be important and would set a significant precedent for future situations. More information:Managing DirectorEgidijus UrbonasTel.: (+370 45) 505 503
South Korea's foreign minister said on Wednesday he hopes the United States will help Seoul address its COVID-19 vaccine shortage as a return in favour of test kits and masks it sent to Washington earlier in the pandemic. The request comes as the South Korean government has come under fire from local media for not doing enough to secure enough vaccines early. It has inoculated just 3% of its population due to tight global supply and limited access.
Chelsea football fans celebrated after their club announced it would pull out of plans for a breakaway Super League.The project is now in tatters after Chelsea, along with five other English clubs, said they would no longer be involved.Manchester City were the first to back out of the venture, just 48 hours after agreeing to join Italian and Spanish teams in the controversial elite competition.Arsenal, Manchester United, Liverpool, Tottenham Hotspur and Chelsea then announced they were following suit.The Super League has faced widespread criticism from within the game and beyond.Sports officials, teams and fan organizations have said the exclusive Super League would increase the power and wealth of elite clubs.Even governments have weighed in.British Prime Minister Boris Johnson said he would consider legislation to stop the breakaway, likening the plans to creating a cartel.There were also threats of bans and sanctions from the game's European and world governing bodies UEFA and FIFA.In response to the departure of English clubs, the European Super League said it would now focus on efforts to "reshape the project," but stopped short of abandoning it altogether.In a statement on Tuesday, the League said, "Given the current circumstances, we shall reconsider the most appropriate steps to reshape the project, always having in mind our goals of offering fans the best experience possible."Most of the English clubs made only brief statements but Arsenal apologized to their fans for being involved.
Bulk Data Centers appoints Gisle Eckhoff Executive Vice President effective September 1, 2021
A Navy officer who set fire to four hotel room towels after being informed that the room could only accommodate two people instead of him and his two companions was jailed three months on Wednesday (21 April).
It's almost identical to a $79 throw from Temple and Webster and pairs perfectly with the Kmart rattan bedhead hack.
(Bloomberg) -- Even as China grows in economic and military power, perhaps nothing reveals Beijing’s weaknesses more than the U.S.’s control of the global financial system.China has recently sought ways to counteract U.S. sanctions after the Trump administration targeted Chinese officials and companies over policies from the South China Sea to Xinjiang. Hong Kong’s leader can’t access a bank account and a top executive at Huawei Technologies Co. is detained in Canada. Even China’s state-run banks are complying with U.S. sanctions.That’s one reason the Biden administration is starting to study whether China’s development of a digital currency will make it harder for the U.S. to enforce sanctions, Bloomberg reported earlier this month. The digital yuan, which could see a wider roll out at the 2022 Winter Olympics in Beijing, is also spurring the U.S. to consider creating a digital dollar.But instead of challenging U.S. dollar dominance and neutralizing sanctions, the digital yuan appears potentially more geopolitically significant as leverage over multinational companies and governments that want access to China’s 1.4 billion consumers. Since China has the ability to monitor transactions involving the digital currency, it may be easier to retaliate against anyone who rebuffs Beijing on sensitive issues like Taiwan, Xinjiang and Hong Kong.“If you think that the United States has a lot of power through our Treasury sanctions authorities, you ain’t seen nothing yet,” Matt Pottinger, former U.S. deputy national security adviser in the Trump administration, said last week at a hearing of the government-backed U.S.-China Economic and Security Review Commission. “That currency can be turned off like a light switch.”So far China has mostly resisted hitting foreign firms in response to U.S. actions on companies like Huawei, holding off on releasing an “unreliable entity list” designed to punish anyone who damages national security. Any move to cut off access to the digital yuan would carry similarly high stakes, potentially prompting foreign investors to pack up and leave.But Beijing has gone after companies like Hennes & Mauritz AB for statements on human-rights issues, even while government officials have been careful to avoid directly endorsing a boycott. In a Weibo post last month, the Communist Party Youth League declared: “Want to make money in China while spreading false rumors and boycotting Xinjiang cotton? Wishful thinking!”Controlling access to China’s massive market remains the best way for Beijing to hit back at the U.S.: As long as Chinese companies still want access to the broader financial world dominated by the U.S. and its allies, Washington can effectively wield sanctions against nearly anyone who doesn’t operate exclusively in China’s orbit. And Beijing has little incentive to shun the dollar.While President Xi Jinping has called for greater self-sufficiency in key technologies like advanced computer chips, a financial decoupling from the U.S. would only hurt China’s economy and potentially leave the Communist Party more exposed to destabilizing attacks. After Xi effectively ended Hong Kong’s autonomy last year with a sweeping national security law, the U.S. refrained from cutting off the territory’s ability to access U.S. dollars due to the potential devastation to the global financial system.‘Great Commercial Risk’Widespread use of the digital yuan -- also known as the e-CNY -- could potentially give China’s central bank more data on financial transactions than the big tech giants, allowing the Communist Party to both strengthen its grip on power and fine-tune policies to bolster the economy. While that level of control may boost growth in the world’s second-biggest economy, it also risks spooking companies and governments already wary of China’s track record on intellectual property rights, economic coercion and rule of law.China’s state-endorsed boycott of H&M shows “great commercial risk” for companies that use the digital yuan, Yaya Fanusie, adjunct senior fellow at the Center for a New American Security in Washington, told the U.S.-China Economic and Security Review Commission hearing. If foreign merchants had to use the e-CNY, he said in a separate email, the government could prohibit transactions with H&M wallets and the store could disappear from digital yuan apps.“This is the other side of the coin -- Beijing not as a sanctions evader, but more empowered to enforce its own financial muscle,” said Fanusie, who has written extensively on how central bank digital assets may impact U.S. financial sanctions. “China’s digital currency is as much about data as it is about money,” he added. Foreign firms that use the digital yuan “might end up handing over to the Chinese government lots of real-time data that it could not access efficiently through conventional banking technology.”China’s ability to see every transaction may make it difficult for foreign banks to use the digital yuan and still comply with confidentiality rules in their home countries, according to Emily Jin, a research assistant at the Center for a New American Security. But, she added, the currency might appeal to some regimes that prioritize control over privacy protection.“They might find it easier to convince governments more authoritarian in their leaning that it helps monitor elicit activities or stop them quickly or stop them before they happen,” Jin said. “They aren’t going to market it to everyone.”The digital yuan would serve as a back-up to Ant Group Co.’s Alipay and Tencent Holdings Ltd.’s WeChat Pay, which together make up 98% of the mobile-payments market, according to Mu Changchun, director of the central bank’s Digital Currency Research Institute. Last month he said the electronic yuan has the “highest level of privacy protection” and the central bank wouldn’t directly know the identity of users, but the government could get that information from financial institutions in cases of suspected illegal activity.Dollar ChallengeChinese policy makers have also repeatedly emphasized that the digital yuan isn’t meant to challenge the dollar, with People’s Bank of China Deputy Governor Li Bo saying last weekend the motivation for the e-CNY is primarily for domestic use. Former PBOC governor Zhou Xiaochuan downplayed the risks of the technology to the global financial system at the Boao Forum on Wednesday, saying the digital yuan will be used mainly for small retail payments.The Chinese currency now makes up about 2% of global foreign exchange reserves compared with nearly 60% for the U.S. dollar, and most of Beijing’s trade and loans in Xi’s Belt-and-Road Initiative are disbursed in dollars.Any serious challenge to the dollar’s position as the world’s reserve currency would also require significant policy changes from China, including lifting capital controls that help the Communist Party keep a lid on sudden outflows that could trigger a financial crisis. Even if the digital yuan could be transacted more cheaply outside of U.S.-controlled global payment systems, it’s unclear if anyone would use it.“The dollar is not the dominant reserve currency because the Americans say it must be,” said Michael Pettis, finance professor at Peking University and senior fellow at the Carnegie-Tsinghua Center in Beijing. “The dollar is the dominant reserve currency because the Chinese, the Europeans, the Japanese, the South Koreans etc. say it must be. It’s the rest of the world that imposes that because they think its the safest place to park money.”The U.S. still has an incentive to set standards for digital currencies. In a survey last year of 65 central banks representing 91% of global economic output, the Bank of International Settlements found more than half were experimenting with digital currencies and 14% were moving forward to pilots. The U.S. itself is taking a cautious approach: Federal Reserve Chair Jerome Powell said last month policy makers must understand the costs and benefits of a digital dollar, and wouldn’t rush the “very, very large, complex project.”‘Wake Up Call’China began research on the digital yuan back in 2014, right after the price of Bitcoin surged from $13.40 to more than $1,000, raising the risk that digital currencies could impact Beijing’s control of monetary policy. It has begun technical testing with Hong Kong for cross-border payments, and is working with Thailand and the United Arab Emirates on real-time foreign exchange settlements. Authorities are also studying how the digital yuan can be combined with 5G networks and the internet of things.This kind of research allows China a greater say in how other countries across the globe design digital currencies, particularly when it comes to questions of surveillance, privacy and anonymity, according to Josh Lipsky, director of the Atlantic Council’s GeoEconomics Center.“China is really leading in this area and it should be a wake up call to the U.S. and to Europe,” Lipsky said. “There is a serious first mover advantage not because of what China will do, but what other countries are doing.”(Updates with comments for former PBOC governor Zhou Xiaochuan in 16th paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Coca-Cola Amatil will be removed from the ASX after 50 years as a public company, due to its sale to Coke Europe.The Australian bottler, which distributes a range of drinks across the Asia Pacific region, will on Thursday disappear from the market after a NSW court approved Coca-Cola European Partners' purchase.
China's President Xi Jinping will attend a U.S.-led climate change summit on Thursday.It will be the first meeting between Xi and Biden since the advent of the new U.S. administration.One of Biden's first moves since taking office was to re-enter the United States into the 2015 Paris Agreement.The need to tackle climate change has been one of the few issues Washington and Beijing have been able to agree on.They continue to be at loggerheads over alleged human rights abuses and China's economic clout over other nations.Last week, U.S. climate envoy John Kerry traveled to Shanghai to meet with his Chinese counterpart.It was the first high-level visit to China by a Biden administration official, and both agreed concrete actions to reduce emissions.China's foreign ministry says Xi will attend the summit via video and will deliver a speech.He's one of dozens of world leaders Biden has invited to the two-day virtual event.
QIAGEN with DiaSorin, announce the launch of LIAISON® LymeDetect® Assay based on QuantiFERON technology for early diagnosis of Lyme Borreliosis
Bred with care and cured for up to two years, the exquisite flavour speaks for itself
In Q1 2021, net loan portfolio of Coop Pank grew by 25 million euros (+4%), reaching 696 million euros. Home loans portfolio showed the fastest growth, increasing the volume by 17 million euros (+6%). Business loans portfolio increased by 8 million euros (+3%), leasing portfolio by 1 million euros (+1%) and consumer finance portfolio decreased by 0.4 million euros (-1%). Compared to Q1 2020, total loan portfolio of Coop Pank has grown by 192 million euros, i.e. 38%. In Q1 2021, volume of deposits in Coop Pank increased by 91 million euros (+12%), reaching total of 849 million euros. Volume of demand deposits grew by 31 million euros (+10%), of which 16 million euros came from private individuals and 15 million euros came from business clients. Term deposits grew by 60 million euros (+13%): 29 million euros came from domestic companies and 5 million euros came from private clients and 26 million euros came via the international deposit-taking platform Raisin. Compared to Q1 2020, volume of Coop Pank's deposits has increased by 301 million euros (+55%). In an annual comparison, share of demand deposits has increased from 30% to 39% and the bank’s financing cost decreased from 1% to 0.8%. In Q1 2021, overdue loan portfolio of Coop Pank was at the level of 3%, which is at the same level as in Q4 2020. In an annual comparison, overdue loan portfolio decreased from the level of 7% to 3%, which is the lowest level in last four years. Impairment costs in Q1 2021 were 0.8 million euros, which is at comparable level as in Q4 2020, but 36% lower than a year ago. Coop Pank has 93,200 clients by the end of Q1 2021, the number of clients has increased by 6,500 over the quarter (7%). Number of private clients with current account in the bank increased by 5,900 and number of business clients by 600 over the quarter. Over the year, client base of Coop Pank increased 34%, i.e. by 24,000 clients. Net income of Coop Pank in Q1 2021 was EUR 8.9 million, having grown 4% QoQ and 25% YoY. Operating expenses reached 5.1 million euros in the first quarter, having decreased by 3% QoQ. In annual comparison, the bank's expenses have increased by 15%. In Q1 2021, net profit of the bank was 2.8 million euros, which is 17% more than in Q4 2020 and 94% more than a year ago. In Q1 2021, cost / income ratio of the bank was 58% and return on equity was 11.5%. As of 31 March 2021, Coop Pank has 15,875 shareholders, 3008 shareholders have been added over the quarter. Margus Rink, Chairman of the Management Board of Coop Pank, comments the results: “Of the first quarter results, the rapid growth of domestic deposits deserves the most attention. In the first quarter of the year, volume of Coop Pank's deposits increased by 91 million euros, of which domestic deposits accounted for more than two thirds, more precisely 65 million euros. Of this, 44 million came from business customers and 21 million from private customers. In addition, we took advantage of the favorable interest rate environment on the international deposit-raising platform Raisin and raised an additional EUR 25 million, reckon with that in the second quarter higher-term term deposits will end on the same platform and we are not planning to extend them. Growth of the bank's business volumes is also accompanied by better performance indicators for investors. Coop Pank's net profit was almost twice as high as a year ago. Cost / income ratio decreased to 58%, cost of financing decreased to 0.8% and return on equity increased to 11.5%. To support further growth strategy, the bank issued subordinated bonds in March. This was the first series in 20 million euros subordinated bonds programme of Coop Pank. Initial issue volume of 8 million euros was oversubscribed 6.2 times, which confirms investors' trust and confidence in the bank's growth plans. We decided to increase the volume to 10 million euros and to give preference to our customers and shareholders in the distribution of the bonds, to whom we distributed two thirds of the total volume of the bonds.” Income statement, in thousands of eurosQ1 2021Q4 2020Q1 2020Net interest income8 0437 8086 358Net fee and commission income648540521Net other income202171238Total net income8 8938 5197 117Payroll expenses-2 879-2 976-2 662Marketing expenses-306-350-226Rental and office expenses, depreciation of tangible assets-579-539-563IT expenses and depreciation of intangible assets-740-767-490Other operating expenses-619-640-501Total operating expenses-5 123-5 272-4 442Net profit before impairment losses3 7703 2472 675Impairment costs on financial assets-771-715-1 214Net profit before income tax2 9992 5321 461Income tax expenses-164-1080Net profit for the financial year2 8352 4241 461Basic earnings per share (in euros)0.030.030.02Diluted earnings per share (in euros)0.030.030.02 Statement of financial position, in thousands of euros31.03.202131.12.202031.03.2020Cash and cash equivalents249 416170 750119 480Debt securities3 0743 0113 737Loans to customers695 721670 593504 119Other assets26 70025 55525 341Total assets974 911869 909652 677Customer deposits and loans received848 755757 835547 398Other liabilities8 6267 4437 696Subordinated debt17 1117 0647 111Total liabilities874 492772 342562 205Equity100 41997 56790 472Total liabilities and equity974 911869 909652 677 The reports of Coop Pank are available at: https://www.cooppank.ee/en/reporting Coop Pank will organise a webinar on 21 April 2021 at 09:00 AM, to present the financial results of Q1 2021. For participation, please register in advance at: https://attendee.gotowebinar.com/register/8859051472217070093 The webinar will be recorded and published on the company's website www.cooppank.ee as well as on the Nasdaq Baltic youtube.com channel. Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The bank has 93,200 daily banking clients. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring everyday banking services closer to people’s homes. The strategic shareholder of the bank is the domestic retail chain Coop Eesti, comprising of 330 stores. Additional information:Kerli LõhmusCFOPhone: +372 669 0902E-mail: firstname.lastname@example.org Attachments Coop Pank 2021 Q1 results_EN Coop Pank 2021-03_EN Interim report_3m 2021_EN
The Annual General Meeting will be broadcasted live by the Company Shareholders are invited to vote at the General Meeting either by mail or by proxy MARSEILLE, France, April 21, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 11:00 a.m. CET on May 28, 2021. The Annual General Meeting will be broadcasted live. The procedures for holding the AGM have been adapted in accordance with French Ordinance No. 2020-321 of 25 March 2020 (as modified by French Ordinance n°2020-1497 of December 2, 2020) and French Decree No. 2020-418 of April 10, 2020 (as modified by French Decree No. 2020-1614 of December 18, 2020), extended by French Decree No. 2021-55 of March 9, 2021. At the date of this publication, administrative measures limiting or prohibiting travel or collective gatherings for health reasons in France prevent the physical presence of its members to the AGM. In this exceptional context, the shareholders are invited to vote before the AGM by correspondence or through a proxy. The shareholders will be able to send questions during the AGM. The connection details and the recording will be available on the Company’s website (www.innate-pharma.com). The Notice of Meeting of this AGM was published on April 21, 2021 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. All documentation regarding this AGM will be published on the Company’s website. Precision regarding the AGM: Only shareholders having registered their shares at least two business days prior to the date of the AGM, by midnight Paris time, will be able to participate. Shareholders holding “au porteur” (bearer) shares will need to obtain an “attestation de participation” (certificate of shareholding) from their brokers. This “attestation de participation” must be attached to the voting or proxy form. Written questions from shareholders must be received the second business day prior to the AGM at the latest (by e-mail to email@example.com). Shareholders may obtain the legal documentation in preparation of the AGM (as described in article R. 225-83 of the French Code de Commerce) by sending a request by e-mail to firstname.lastname@example.org. About Innate Pharma: Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb, Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca. Headquartered in Marseille, France, with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US. Learn more about Innate Pharma at www.innate-pharma.com Information about Innate Pharma shares: ISIN code Ticker code LEIFR0010331421 Euronext: IPH Nasdaq: IPHA 9695002Y8420ZB8HJE29 Disclaimer: This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995.The use of certain words, including “believe,” “potential,” “expect” and “will” and similar expressions, is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company’s commercialization efforts, the Company’s continued ability to raise capital to fund its development and the overall impact of the COVID-19 outbreak on the global healthcare system as well as the Company’s business, financial condition and results of operations. For an additional discussion of risks and uncertainties which could cause the company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (“Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority (“AMF”), which is available on the AMF website http://www.amf-france.org or on Innate Pharma’s website, and public filings and reports filed with the U.S. Securities and Exchange Commission (“SEC”), including the Company’s Annual Report on Form 20-F for the year ended December 31, 2019, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company. This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country. For additional information, please contact: InvestorsInnate Pharma Tel.: +33 (0)4 30 30 30 email@example.com MediaInnate Pharma Tracy Rossin (Global/US)Tel.: +1 240 801 0076Tracy.Rossin@innate-pharma.comATCG PressMarie Puvieux (France)Tel.: +33 (0)9 81 87 46 firstname.lastname@example.org
NEWS RELEASE - REGULATED INFORMATION21 APRIL 2021, 07:00 A.M. CET IRVINE, CA, and HERSTAL, BELGIUM – April 21, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for the first quarter ended March 31, 2021. Michael McGarrity, CEO of MDxHealth, commented: “We believe our results support our positive view forward as we come through the effects of the pandemic on our business and patient flow in our U.S. market. We remain confident that the fundamentals we have driven into our operating discipline and commercial execution will continue to be demonstrated and reflected in our results going forward. “Our sequential growth in unit volume for ConfirmMDx for the third quarter in a row, coupled with 23% sequential growth in revenue is clear evidence of our recovery from the pandemic-induced decline in patient flow and screenings for prostate cancer, as previously noted, to be down roughly 50%. As expected, our ConfirmMDx results reflect an opening of patient flow and we expect SelectMDx to follow as restrictions ease, vaccinations roll out, and our inclusion in the NCCN guidelines continues to take hold. All of these leading indicators point to a turn to sustainable growth and we look forward to providing additional guidance with our mid-year results in August.” Highlights for the first quarter ended March 31, 2021 Successful completion of a EUR 25 million (approximately $30.4 million) capital increase in January 2021, with broad support from U.S. and European investors including continued support from our Reference shareholders, MVM, Valiance and BioVestTotal revenue of $5.1 million, down 14% from $5.9 million in Q1-2020, and up 23% sequentially from Q4-2020Sequential growth of 6% in ConfirmMDx units compared to Q4-2020Cash and cash equivalents of $38.2 million as of March 31, 2021 Summary of billable test volume by product Products Quarter Ended March 31,20212020% ChangeConfirmMDx 3,9134,532(14)%SelectMDx3,5294,383(26)% Subsequent events On April 19, 2021, MDxHealth and Kreos Capital executed an amendment to the 2019 loan facility, extending the interest-only period from 18 months to 27 months. As a result of this amendment, repayment of principal has been extended from May 2021 to February 2022. As part of the amendment, the Company agreed to increase the end-of-loan fee by an additional €67,500 (approx. $80,000) as well as to provide for an additional €202,500 of the €9 million loan to be convertible into shares of MDxHealth at a 25% premium to the 30-day volume weighted average price 10 days prior to signing the amendment. If exercised, this amount will be reduced from the principal amount due under the loan agreement. About MDxHealth MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company’s European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth. For more information: MDxHealth email@example.com This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company’s control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of MDxHealth in any jurisdiction. No securities of MDxHealth may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. securities laws. NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, and SelectMDx are trademarks or registered trademarks of MDxHealth SA. Attachment MDxHealth
In the 1st quarter of 2021, the spread of coronavirus continued to affect our ways of working in Tallinna Vesi. Despite the changes made in the work arrangements, the company delivered excellent results for a number of parameters. We are pleased to see consistently high performance in the quality of drinking water and customer service. Cold temperatures in the beginning of the year affected both the level of leakages in the water network as well as the time it took to fix those. High-quality drinking water Water quality in the first three months of the year was 100% compliant with all quality requirements. This means that all the 893 water samples taken from the network during the first quarter met the strict water quality standards. Excellent drinking water quality in the network has been ensured by the efficient management of water treatment processes, proactive network maintenance and low raw water temperature being a contributing factor. We work hard to limit interruptions in the water network and minimise their duration when they occur. The average water disruption time was 3 hours and 19 minutes, with 93% of emergency interruptions lasting less than 5 hours. To minimise the effect of water interruptions on customers, we continue the additional valve installation project also in 2021. The level of leakages in our network was 15.46% in the first three months, showing a slight increase year on year, attributable to the cold weather and reduced consumption. In terms of enhancing the reliability of water supply service to customers, we commenced network reconstruction works in Poska and Roosikrantsi streets and Kadaka road. During the 1st quarter of 2021, the company built a total of 1,370 m of water pipes and 650 m of sewers. Reliable wastewater service Besides the sustainable use of water, we are also determined to improve the natural and living environment around the Baltic Sea by assessing the treatment efficiency and the quality of wastewater. We consistently monitor the concentration of pollutants in the incoming wastewater and final treated effluent. The quality of treated effluent leaving Paljassaare wastewater treatment plant has direct impact on the marine environment. During the first three months it continued to be fully compliant with all regulations and standards. In the 1st quarter of 2021, the number of sewer collapses was approximately 30% lower year on year, which was a good reflection of the Company’s enhanced maintenance regimes and targeted investments. The number of sewer blockages in the network increased 15% year on year, primarily due to lower temperatures in winter compared to the last year. The reconstruction of the mechanical treatment stage at Paljassaare wastewater treatment plant continued according to the plan. We made preparations for puting into operation the new grit traps that are part of the mechanical treatment stage. This is one of the largest projects of the past decade for the Company and will continue throughout 2021. Completion of this project will further enhance the quality and resilience of wastewater treatment process. We also upgraded the key facility of the sewer system in the city, the main pumping station at wastewater treatment plant, receiving all the wastewater collected from Tallinn. To reduce the operational risks of the plant, a new pump was installed at the main pumping station that will provide 5-10% additional capacity for incoming wastewater. The new pump will enhance resilience of the wastewater treatment process at times of heavy rainfall and will further increase the reliability of supply for Tallinners. High standards of customer service To deliver high-quality service to our customers we have set ourselves clear and challenging targets also for this year. We aim to keep our promises made to customers concerning the speed of our response and problem-solving. During the first three months, we failed one promise, which affected two customers. The failure was related to a planned interruption to water supply, where the opening of water supply was delayed by 2 hours due to our contractor’s fault. The first three months of 2021 saw a decrease in the number of written inquires and repeated requests. This positive trend shows a stable improvement in the quality of service and, on the other hand, indicates that information is easily available to customers through other channels such as our website or self-service. The number of customer complaints was also significantly lower than in the same period last year. OPERATIONAL INDICATORS FOR THE THREE MONTHS OF 2021 Indicator Unit Q1 2021 Q1 2020Drinking water Compliance of water quality at the customers’ tap%100%100%Water loss in the water distribution network%15.46%14.9%Average duration of water interruptions per property in hoursh3.322.87Wastewater Number of sewer blockagesNo143124Number of sewer collapsesNo1927Wastewater treatment compliance with environmental standards%100%100%Customer Service Number of complaintsNo816Number of customer contacts regarding water qualityNo4264Number of customer contacts regarding water pressureNo5164Number of customer contacts regarding blockages and leading off stormwaterNo244266Responding to written customer contacts within at least 2 working days%99.7%100%Number of cases of failed promisesNo10Notification of unplanned water interruptions at least 1h before the interruption%99.8%99.4% Laura KorjusHead of CommunicationTallinna Vesi(+372) 626 firstname.lastname@example.org
Press releaseEmbargo until 21 April 2021 at 7:00 am Regulated information – Inside information Financial information for the first quarter 2021 Positive results despite impact of Covid-19 and strained competitive environment Mobile postpaid customer base +3.0% yoy / Cable customer base +24.8% yoyQ1 Revenues -1.0% yoy / Q1 Retail service revenues +1.9% yoy Q1 EBITDAaL +12.8% yoy, +4.6% yoy excluding seasonality effect 2021 guidance confirmed Q1 Operational Highlights Commercial performance remained solid amid a tougher competitive environment and on-going Covid-19 measures that limited the shops’ full capacity. Go portfolio remains a success, with Go Unlimited special edition gaining traction. During the quarter, 23k new mobile postpaid customers were added, reaching 2.7m subscribers (+3.0% yoy). Cable net adds continued to be strong with 23k new customers. One third of the gross adds are Love Duo customers, confirming the commercial trend of former quarters. Convergent mobile subscribers continued to grow and now represent 21.3% of mobile postpaid customers vs 17.4% achieved in Q1’20.Mobile only postpaid ARPO declined by 3.4% yoy to €19.6, due to the decrease in out-of-bundle revenues.B2C convergent ARPO decreased by 2.8% yoy to €73.8, mainly explained by the discounts provided on mobile tariff plans in convergence, as well as the continuous growth of Love Duo in the customer base, decreasing the overall ARPO. Orange Belgium: key operating figures Q1 2020 Q1 2021 change Mobile postpaid customer base (in ‘000) 2,588 2,664 3.0% Net adds (in ‘000) 9 23 160.5% Mobile only postpaid ARPO (€ per month) 20.3 19.6 -3.4% Cable customer base (in ‘000) 280 349 24.8% Net adds (in ‘000) 21 23 6.8% B2C convergent ARPO (€ per month) 75.9 73.8 -2.8% Cable customer as % mobile contract customer base 17.4% 21.3% 386 bp Q1 Financial Highlights Revenues reached €330.4m, down 1.0% yoy. Retail service revenues continued to grow by 1.9%, mainly thanks to higher convergent service revenues (+16.9% yoy). As in past quarters, Covid-19 impacted wholesale revenues (-16.0% yoy), mainly due to lower incoming SMS revenues (-€12.3m, offset by lower SMS costs). EBITDAaL grew 12.8% yoy to €70.1m, driven by higher retail service revenues, supported by lower costs (-4.2% yoy). There was a €3.6m tailwind from seasonality in advertising and promotional spend linked to the launch of Go offers in Q1’20 and €1.5m one-off related to roaming. Excluding those effects the EBITDAaL had grown +4.6% yoy to €65.0m.eCapex (excluding spectrum licence fees) increased slightly by 2.6% yoy to €36.1m. 2021 financial guidance confirmed: Orange Belgium expects low single-digit revenue growth, EBITDAaL of between €320m and €340m and eCapex between €200m and €220m. Orange Belgium Group: key financial figures in €m Q1 2020 Q1 2021 change Revenues 333.9 330.4 -1.0% Retail service revenues 224.8 229.0 1.9% EBITDAaL 62.2 70.1 12.8% margin as % of revenues 18.6% 21.2% 260 bp eCapex 1 -35.1 -36.1 2.6% Operating cash2 27.0 34.1 26.0% Net financial debt 229.0 122.6 eCapex excluding licence fees. In Q1 2020 Orange Belgium paid 10.9 million euros on licence fees.Operating cash flow defined as EBITDAaL – eCapex excluding licence fees Xavier Pichon, Chief Executive Officer, commented: The first quarter of the year was characterised by both an ever-straining competitive environment together with the extension of the Covid-19 policies. Our shops remained open but with limited capacity in accordance with the recommendations of the competent authorities. Thanks to our Team members’ commitment, we were even able to offer an improved customer experience and to attract new customers with numbers comparable to pre-pandemic levels. Despite the challenges we are facing, Orange Belgium has shown strong resilience and delivered solid commercial and financial results for this quarter. Antoine Chouc, Chief Financial Officer, stated: The positive commercial performance also resulted in good financial results. Despite the sanitary crisis, we were once again able to grow in terms of retail service revenues, confirming the resilience of our activity. Thanks to our transformation programme, seasonality effect in our indirect costs as well as the one-off in roaming, we managed to improve the EBITDAaL in comparison to the first quarter of 2020. The first quarter gives us the necessary assurance that we will achieve our guidance announced last quarter. Attachment ENG Q1 2021 - FV
(2021-04-21) Kitron today reported quarterly figures showing strong growth within the market sectors Electrification and Industry. Kitron’s revenue for the first quarter was NOK 938 million, an increase of 7 per cent compared to last year. Profitability expressed as EBIT margin was 7.0 per cent in the first quarter, compared to 6.7 per cent in the same quarter last year. Peter Nilsson, Kitron's CEO, comments:“We continue to capitalize on two of the most fundamental changes in the global economy: the move to renewable energy and electrification and the rapid growth in machine-to-machine communications. The demand is very strong. However, as the general material supply situation is challenging, Kitron’s operations will have to be flexible to deliver the demand. In general, the first quarter demonstrates that Kitron’s growth follows the strategic path we outlined at our capital markets presentation in March.” Increased revenueKitron’s revenue for the first quarter was NOK 938 million, compared to NOK 878 million in the same quarter last year. Growth adjusted for foreign exchange effects in consolidation was 9 per cent. As previously reported, Kitron has realigned the market sectors the company reports on to better reflect current activity as well as identified growth opportunities. Two new market sectors are added: Electrification and Connectivity. In the first quarter there was strong revenue growth within the Electrification, Connectivity and Industry sectors, while revenue declined within Defence/Aerospace. As expected, revenue within Medical devices has gradually been normalized after the pandemic-related demand surge during 2020. Solid order backlogThe order backlog ended at NOK 2 060 million, virtually unchanged from last year. The order backlog increased within the Electrification, Connectivity and Industry sectors. As expected, the order backlog within Medical devices declined. Adjusted for changes in currency rates, the order backlog increase was 8 percent compared to last year. Improved profitability First quarter operating profit (EBIT) was NOK 65.4 million, compared to 58.4 million last year. EBITDA was NOK 90.2 million, compared to 82.7 million last year. Profit after tax was NOK 43.4 million compared to 40.9 million in the same quarter the previous year. This corresponds to earnings per share of NOK 0.24, up from 0.23 last year. Strong operating cash flow Operating cash flow was NOK 78.3 million, compared to 102.4 million in the first quarter of 2020. Net working capital was NOK 1 035 million, an increase of 2 per cent compared to the same quarter last year. Capital efficiency ratios are expected to improve moving forward. OutlookFor 2021, Kitron expects revenue between NOK 3 900 and 4 200 million. EBIT margin is expected to be between 6.8 and 7.4 per cent. The outlook for 2021 implies that Kitron is back on its long term trajectory for revenue and profitability after exceptional growth in 2020, largely driven by Corona-related demand within the Medical devices sector. Growth is driven by Connectivity, Electrification, and Industry sectors. The Medical devices sector is expected to be normalised and in line with previous years. The outlook for Defence/Aerospace is slightly down. Enclosed in PDF are the quarterly report and the presentation. The interim report is presented today at 8:30 a.m. CEST. The presentation will be given in English by CEO Peter Nilsson and CFO Cathrin Nylander, and will be webcast at the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210421_1 For further information, please contact:Peter Nilsson, President and CEO, tel. +47 94 84 08 50Cathrin Nylander, CFO, tel: +47 900 43 284E-mail: email@example.com Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The company is located in Norway, Sweden, Lithuania, Germany, Poland, China and the United States. Kitron had revenues of about NOK 4.0 billion in 2020 and has about 1 800 employees. www.kitron.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments Kitron 2021 Q1 report Kitron 2021 Q1 Presentation
The AGM will take place Thursday, May 27, 2021, 14:00 CEST at Cavotec SA headquarters in Lugano, Switzerland (Via G.B. Pioda 14, Lugano). IMPORTANT COMMUNICATION: no personal attendance and exercise of rights exclusively through the Independent Proxy In view of the current situation involving the spread of the Covid-19, it will not be possible to attend the Annual General Meeting in person. As a result, the Board of Directors based on art. 27 of the Ordinance 3 on Measures to Combat the Coronavirus (COVID-19; SR 818.101.24 of 19 June 2020 – Status as of 15 April 2021) decided that the shareholders of Cavotec SA may exercise their rights at the Annual General Meeting exclusively through the Independent Proxy. For more information regarding the appointment of the Independent Proxy please refer to the “Participation” section below. AGENDA AND PROPOSALS OF THE BOARD OF DIRECTORS 1. Appointment of the Chairman of the day According to the Art. 11 of the Articles of Association, general meetings of shareholders are presided over by the Chairman of the Board of Directors or, in his absence, by a Chairman of the day to be elected by the general meeting of shareholders. Due to the restrictions imposed by the Covid-19, Mr. Patrik Tigerschiöld, Chairman of the Board of Directors, is not able to attend the Annual General Meeting in person. In consideration of the justified absence of Mr. Patrik Tigerschiöld, the Board of Directors proposes that Mr. Massimo Vanotti, Attorney-at-law, Bär & Karrer SA , be appointed as Chairman of the day for the Annual General Meeting. 2. Annual report, financial statements and consolidated financial statements for the year 2020, report of the Statutory Auditors The Board of Directors proposes that the annual report, the financial statements and the consolidated financial statement for the year 2020 be approved. Please refer to the “Documentation” section below. 3. Appropriation of available earnings The Board of Directors proposes the following appropriation: CHF Carried forward from previous years (42,898,901)Net gain/loss for the financial year 2020 (1,243,820)Total earnings available (44,142,720) Appropriation to general statutory reserves (retained earnings) -Appropriation to other reserves -Proposed balance to be carried forward (44,142,720) 4. Grant of Discharge from Liability to the Board of Directors and Persons entrusted with the Management from Activities during Business Year 2020 The Board of Directors proposes that discharge be granted to all the members of the Board of Directors and the Persons entrusted with the Management for the business year 2020. 5. Cancellation of provisions concerning expired contingent share capital The Articles of Association contain provisions relating to contingent share capital, allowing the Company to increase the share capital through the issuance of new shares to employees of the Company and group companies (i.e. Art. 4ter, 4quinquies, 4sexies, 4septies and 4octies). The shares or rights to subscribe for shares shall be issued to employees pursuant to the respective Long Term Incentive Plan approved by the Board of Directors. The Board of Directors informs the shareholders that the Long Term Incentive Plans 2012, 2013, 2014, 2015 and 2016 are expired and no shares have been issued to employees through the implementation of contingent share capital pursuant to Art. 4ter, 4quinquies, 4sexies, 4septies and 4octies. These provisions are hence outdated and may no longer be implemented. Therefore, the Board of Directors proposes to cancel the articles 4ter, 4quinquies, 4sexies, 4septies and 4octies of the Articles of Association. As a result, the current art. 4quater and 4nonies will be renumbered to Art. 4ter and 4quarter. 6. Creation of additional contingent share capital in connection with employee participation The Board of Directors proposes to create additional contingent share capital in an amount not to exceed CHF 1’206’310.40 enabling the issuance of up to 942’430 additional shares with a nominal value of CHF 1.28 each in connection with employee participation (Long Term Incentive Plan 2021-2023) by inserting the new article 4quinquies (or new article 4decies, in case of non-approval of the section 5 above) of the Articles of Association with the following wording: Article 4quinquies (or art. 4decies) – Contingent Share CapitalThe share capital may be increased in an amount not to exceed CHF 1’206’310.40 through the issuance of up to 942’430 fully paid registered shares with a par value of CHF 1.28 per share by the issuance of new shares to employees of the Company and group companies. The pre-emptive rights and advance subscriptions rights of the shareholders of the Company shall thereby be excluded. The shares or rights to subscribe for shares shall be issued to employees pursuant to the Long Term Incentive Plan 2021-2023 approved by the Board of Directors. Shares or subscription rights may be issued to employees at a 10% discount compared with the market price quoted on the stock exchange at that time. 7. Renewal of Authorized Share Capital According to Art. 4ter of the Articles of Association the Board of Directors shall be authorized to increase the share capital by up to 20%, i.e. in an amount not to exceed CHF 24’126’259.20 through the issuance of up to 18’848’640 fully paid registered shares with a par value of CHF 1.28 per share, by not later than May 13, 2022. The Board of Directors proposes to extend the duration of the authorized share capital by another year to May 27, 2023 and to reduce the existing authorized share capital from 20% to 10% of the current total share capital, i.e. authorizing the Board of Directors to increase the share capital in an amount not to exceed CHF 12’063’129.60 through the issuance of up to 9’424’320 fully paid registered shares with a par value of CHF 1.28 per share. It is the Board of Directors opinion that the suggested reduction from 20% to 10% is more in line with Swedish market practice while still providing sufficient flexibility for the Company. Therefore, the Board of Directors proposes to amend the article 4ter (or art. 4quater, in case of non-approval of the section 5 above) of the Articles of Association as follows: Article 4ter (or art. 4quater) - Authorized Share CapitalThe Board of Directors shall be authorized to increase the share capital in an amount not to exceed CHF 12’063’129.60 through the issuance of up to 9’424’320 fully paid registered shares with a par value of CHF 1.28 per share by not later than May 27, 2023. Increases in partial amounts shall be permitted. The Board of Directors shall determine the date of issue of new shares, the issue price, the type of payment, the conditions for the exercise of pre-emptive rights, and the beginning date for dividend entitlement. In this regard, the Board of Directors may issue new shares by means of a firm underwriting (“Festübernahme”) through a banking institution, a syndicate or another third party with a subsequent offer of these shares to the shareholders. The Board of Directors may permit pre- emptive rights that have not been exercised to expire or it may place these rights and/or shares as to which pre-emptive rights have been granted but not exercised, at market conditions or use them for other purposes in the interest of the Company. The Board of Directors is further authorized to restrict or deny the pre-emptive rights of shareholders and allocate such rights to third parties if the shares are to be used: 1.1 for the acquisition of an enterprise, parts of an enterprise, or participations, or for new investments, or, in case of a share placements, for the financing or refinancing of such transactions; or 2.1 for the purpose of broadening the shareholder constituency in connection with a listing of shares on domestic or foreign stock exchanges or for the purpose of the participation of strategic partners; or 3.1 for the issuance of shares to employees or directors of the Company or of the group companies pursuant to share based incentive plans approved by the Board of Directors. 8. Amendment of the Remuneration Period of the Board of Directors According to the current remuneration approval system, the general meeting of shareholders shall annually approve the maximum aggregate remuneration amount (covering fixed and variable remuneration) each of:• the Board of Directors for the next business year;• the CEO for the next business year. For both the Board of Directors and the CEO, the Articles of Association provide for a prospective approval by the General Meeting, being the approved remuneration period the next business year. The Board of Directors takes the view that a prospective approach guarantees the most stability and legal certainty for the Company and is convinced that it will allow to keep the most qualified executives, which is in the best interests of both the Company and the shareholders. However, the current system has some limitations with regards to the remuneration of the Boards of Directors, considering in particular that the term of office (from ordinary General Meeting until the next ordinary General Meeting) and the remuneration period approved by the shareholders (from 1st January to 31st December) are not aligned. Keeping a prospective approach, the Board of Directors proposes to have the remuneration period of the Board of Directors approved until the next ordinary General Meeting, hence, aligning the term of office and the respective remuneration period. Therefore, the Board of Directors proposes to amend the article 16b of the Articles of Association as follows: Article 16b - Approval of Remuneration by the General Meeting of ShareholdersThe general meeting of shareholders shall annually approve the maximum aggregate amount each of: 1. the remuneration for the board of directors for the period lasting until the next ordinary general meeting of shareholders;2. the remuneration for the CEO for the next business year. The aggregate amount shall cover the fixed remuneration, the STIP and the LTIP payable during the next relevant period. In the event the general meeting of shareholders does not approve a proposal of the board of directors, the board of directors may submit another proposal at the same general meeting of shareholders or convene a new general meeting of shareholders to approve the remuneration. The general meeting of shareholders may at any time approve a subsequent increase of an approved aggregate amount. In case of approval of this item by the Annual General Meeting, the new approved remuneration period will apply immediately (see art. 9.1.A. below) 9. Approval of Remuneration 9.1. Approval of Remuneration for the Board of Directors Scenario A:In the event of approval of the amendment of the remuneration period for the Board of Director in accordance with the above mentioned section 8, the general meeting of shareholders shall annually approve the maximum aggregate remuneration amount (covering fixed and variable remuneration) of the Board of Directors for the period lasting until the next ordinary general meeting of shareholders. The Board of Directors proposes to approve the maximum aggregate amount of EUR 500’000 for the remuneration (covering fixed and variable pay, pension contribution, social charges, etc.) for the Board of Directors for the period lasting until the next ordinary general meeting of shareholders. Scenario B:In the event of rejection of the amendment of the remuneration period for the Board of Director in accordance with the above mentioned section 8, the general meeting of shareholders shall annually approve the maximum aggregate remuneration amount (covering fixed and variable remuneration) of the Board of Directors for the next business year. The Board of Directors proposes to approve the maximum aggregate amount of EUR 500’000 for the remuneration (covering fixed and variable pay, pension contribution, social charges, etc.) for the Board of Directors for the next business year. 9.2. Approval of Remuneration of the CEO According to Art. 16b of the Articles of Association, the general meeting of shareholders shall annually approve the maximum aggregate remuneration amount (covering fixed and variable remuneration) of the CEO for the next business year. The Board of Directors proposes to approve the maximum aggregate amount of EUR 2’900’000 for the remuneration (covering fixed and variable pay, pension contribution, social charges, etc.) for the CEO for the business year 2022. 10. Re-election of five Directors, election of one new Director, nomination of the Chairman of the Board of Directors Pursuant to Art. 13 of the Articles of Association the Directors are elected each year to hold office until the following annual general meeting. Directors may be re-elected. Patrik Tigerschiöld, Fabio Cannavale, Niklas Edling, Annette Kumlien and Erik Lautmann stand for re-election, while Keith Svendsen is proposed for election. Roberto Italia resigned from the Board of Director on December 16, 2020 and does not stand for re-election. The Board of Directors, based on the recommendation of the Nomination Committee, proposes that Patrik Tigerschiöld, Fabio Cannavale, Niklas Edling, Annette Kumlien and Erik Lautmann be re-elected as Directors for a further one-year term of office expiring at the annual general meeting to be held in 2022. The Board of Directors, based on the recommendation of the Nomination Committee, proposes to elect Keith Svendsen to the Board of Directors for a one-year term of office expiring at the annual general meeting to be held in 2022. Keith Svendsen currently serves as COO of APM Terminals, one of the largest port terminal operators in the world with 75 terminals worldwide and close to 22 000 employees. Mr Svendsen joined A.P. Moller-Maersk in 1995 after graduating from Fanø Navigation College in Denmark as a Master Mariner. In 2006 Mr Svendsen earned a Masters in Business Administration from the London Business School. In 1998 Mr Svendsen was appointed to lead the global container hub operations in the East Mediterranean, and he has subsequently held increasingly senior roles in numerous locations around the world over a 30-year career with the A.P. Moller-Maersk. His leadership experience in the ports and maritime sector brings a unique perspective of where the sector is moving, which will be of great benefit for Cavotec as the company embarks on its accelerated growth journey. Mr Svendsen is currently director of a number of entities associated with A.P. Moller-Maersk. The Board of Directors, based on the recommendation of the Nomination Committee, furthermore proposes to nominate Patrik Tigerschiöld as Chairman of the Board of Directors. 11. Nominations for the Remuneration Committee Pursuant to Art. 13 of the Articles of Association the members of the Remuneration Committee are elected each year to hold office until the following annual general meeting. Members of the Remuneration Committee may be re-elected. The Board of Directors, based on the recommendation of the Nomination Committee, proposes that Erik Lautmann, Patrik Tigerschiöld and Fabio Cannavale be re-elected as members of the Remuneration Committee for a further one-year term of office expiring at the annual general meeting to be held in 2022. 12. Re-election of Independent Auditor The Board of Directors, based on the recommendation of the Nomination Committee, proposes that PricewaterhouseCoopers SA, Lugano, Switzerland be re-elected as Cavotec’s independent auditor for business year 2021. 13. Election of an Independent Proxy Pursuant to Art. 9a of the Articles of Association the independent proxy is elected each year to hold office until the following annual general meeting. The independent proxy may be re-elected. The Board of Directors proposes that Mr. Franco Brusa, Attorney-at-law, Via G.B. Pioda 5, Lugano, Switzerland be re- elected as Cavotec’s independent proxy for an additional one-year term expiring at the annual general meeting to be held in 2022. 14. Adoption of the Nomination Committee Charter The Board of Directors proposes that the Nomination Committee Charter shall be adopted and apply until a general meeting resolves otherwise. Please refer to the “Documentation” section below. DOCUMENTATION AND ATTENDANCE PROCEDURES Documentation As of April 21, 2021, the following documents have been made available for inspection by shareholders at our registered office at Via Giovan Battista Pioda 14, 6900 Lugano, Switzerland: • 2020 Annual Report (including audited consolidated financial statements for the business year ended December 31, 2020 and audited statutory accounts of Cavotec SA, as well as the audited Remuneration Report);• Nomination Committee Statement• Remuneration Committee Statement• Corporate Governance Report• Nomination Committee Charter All material for the 2021 AGM is also available on the Company’s website ir.cavotec.com, and shareholders may request copies at no cost of these documents at the following e-mail address: firstname.lastname@example.org. Language The AGM, deviating from the Swedish Corporate Governance Code (the “Code”), will be held in English and information and material will be available in English only. This is in accordance with an exemption granted by the Swedish Financial Supervisory Authority. Participation As announced above the AGM will take place in Lugano, Switzerland, without the personal attendance of shareholders who can exercise their rights exclusively through the Independent Proxy. Therefore, no admission tickets will be sent. Only shareholders entered in the share register with the right to vote on May 20, 2021, will be entitled to appoint the Independent Proxy and give him voting instructions. Further instructions for holders of SIX SIS registered shares and Euroclear Sweden registered shares follow below. You may appoint the following proxy to represent you: • Mr. Franco Brusa, Attorney-at-Law, Via G.B. Pioda 5, Lugano, Switzerland, has been appointed as independent shareholders’ representative pursuant to Art. 9a of the Articles of Association (Independent Proxy). You may use the proxy form attached to your invitation or the Electronic Proxy as set out on: https://anmalan.vpc.se/Cavotec2021 to appoint and instruct the Independent Proxy. Please note that the proxy form is also available on the Company’s website ir.cavotec.com. Electronic Proxy On the website https://anmalan.vpc.se/Cavotec2021 shareholders have the possibility to appoint the independent proxy and to give him instructions electronically. Registered shareholders will receive their personal login data (the “Individual Login”) by regular mail. The proxy granted electronically (the “Electronic Proxy”) has the same validity as the physical Proxy Form. Please note that you cannot vote twice (electronically and by mail); the instructions (electronic or by mail) which have been given later prevail. Additional information on the Electronic Proxy is available on https://anmalan.vpc.se/Cavotec2021. Instructions to participate for Holders of SIX SIS registered shares The following information is to shareholders who hold their Cavotec shares through SIX SIS AG.To exercise your voting right through the Independent Proxy, you must be registered in the share register of Cavotec SA (“Share Register”) and complete the Proxy Form in accordance with the instructions set out below. 1. Registration in the Share Register of Cavotec SA: In order to be entitled to voting rights at the AGM, Shareholders who are not already registered in the Share Register must request to be registered as shareholders in the Share Register prior to May 20, 2021 (the “Record Date”) in accordance with the instructions set out below: • Shareholders must instruct their custodian bank to register them as shareholders in the Share Register of Cavotec SA by sending a Proxy Form to Cavotec SA, c/o Computershare Schweiz AG, Share Register, Baslerstrasse 90, CH-4600 Olten.• The registration in the Share Register may be requested at any time.• The registration must be completed on the Record Date at the latest. Shareholders who are already registered in the Share Register do not have to perform any additional steps and will be provided automatically with the Proxy Form as well as with the Individual Login. Please note that the registration process may take time. To ensure their registration in time for the AGM, shareholders are therefore kindly invited to issue instructions to their custodian bank as soon as possible. 2. Proxy Voting: Shareholders, who are registered in the Share Register, will receive a Proxy Form as well as the Individual Login by regular mail directly from Cavotec SA. Shareholders will be able to appoint the Independent Proxy, Mr. Franco Brusa, Attorney-at-law, Via G.B. Pioda 5, Lugano, Switzerland by using physical Proxy Forms. Alternatively, shareholders will also be able to appoint the Independent Proxy electronically on https://anmalan.vpc.se/Cavotec2021. • The Proxy Form will be sent out via regular mail on April 23, 2021.• In order to vote by proxy, the Proxy Form must be returned to Mr. Franco Brusa c/o Euroclear Sweden AB, PO Box 191, SE-101 23 Stockholm, Sweden, well in advance and in any case before May 21, 2021. In order to vote by Electronic Proxy, the Electronic Proxy must be completed according to the instructions set out on https://anmalan.vpc.se/Cavotec2021 by May 24, 2021, at 2pm at the latest. Instructions to participate for Holders of Euroclear Sweden registered shares The following information is to shareholders who hold their Cavotec shares through Euroclear Sweden AB, which shares trade on the Nasdaq Stockholm Exchange (“Euroclear Registered Cavotec Shares”). To exercise your voting right, you must register your voting rights in the register of shareholders kept by Euroclear Sweden AB (“Register of Shareholders”) and complete the Proxy Form or the Electronic Proxy in accordance with the instructions set out below. 1. Registration Process for Voting Rights: Direct-registered holders:Holders of Euroclear Registered Cavotec Shares who hold their Euroclear Registered Cavotec Shares on an account directly with Euroclear Sweden, a CSD-account (Sw: Vp-konto), will be automatically included in the Register of Shareholders and do not have to perform any registration regarding voting rights. Nominee-registered holders:To be registered and entitled to appoint the Independent Proxy at the AGM, shareholders who hold Euroclear Registered Cavotec Shares via a nominee (“Nominee-registered Holders”) must act in accordance with the instructions set out below:• Nominee-registered Holders must request the nominee to register their Euroclear Registered Cavotec Shares temporarily in their own name in the Register of Shareholders.• The registration in the Register of Shareholders will start on April 29, 2021, 21 calendar days prior to the Record Date.• The registration in the Register of Shareholders must be completed at end of business day at the Record Date at the latest. Nominee-registered holders with Non-affiliated Nominees:To be registered and entitled to appoint the Independent Proxy at the AGM, Nominee-registered Holders who hold their Euroclear Registered Cavotec Shares on custody accounts with nominees that are not affiliated directly as nominees to Euroclear Sweden AB (“Non-affiliated Nominees”) must follow the instructions below:• Nominee-registered Holders with Non-affiliated Nominees must request their custodian bank or their nominee to register their Euroclear Registered Cavotec Shares temporarily in their own name in the Register of Shareholders. To do so, you must instruct the institution where you have your account to forward the registration request to Euroclear Sweden AB through its own custodians and/or nominees.• The registration in the Register of Shareholders will start on April 29, 2021, 21 calendar days prior to the Record Date.• The registration in the Register of Shareholders must be completed at end of business day at the Record Date at the latest. Please note that the registration process may take time in such circumstances. To ensure their registration, shareholders are therefore kindly invited to issue instructions to their Non-affiliated Nominees as soon as possible. 2. Proxy Voting: Nominee-registered Holders and direct-registered holders:Holders of Euroclear Registered Cavotec Shares, registered on either a CSD-account (Sw Vp-konto) or a custody account with a nominee directly affiliated to Euroclear Sweden AB will receive a Proxy Form as well as the Individual Login by regular mail directly from Euroclear Sweden AB. Recipients will be able to appoint the Independent Proxy by using physical Proxy Forms. Recipients will also be able to grant a proxy and issue instructions to the Independent Proxy electronically by using the Electronic Proxy. In case Holders of Euroclear Registered Cavotec Shares intend to appoint the Independent Proxy, the Proxy Form must be filled out, signed, dated and returned to the addresses below well in advance and in any case before May 21, 2021. In order to vote by Electronic Proxy, the Electronic Proxy must be completed according to the instructions set out on https://anmalan.vpc.se/Cavotec2021 by May 24, 2021, at 2pm at the latest. Nominee-registered Holders with Non-affiliated nominees:In order to appoint the Independent Proxy, Nominee-registered Holders with Non-affiliated Nominees must:• Download the Proxy Form from the web site www.cavotec.com. The form will be available from April 22, 2021.• Print and fill out the Proxy Form downloaded from www.cavotec.com and return it signed and to the address below well in advance and in any case before May 21, 2021. Additional Instructions for Non-affiliated Nominees:Non-affiliated Nominees are urged to forward the above information to their custody-account holders holding Euroclear Registered Cavotec Shares. Other information As of the date of this notice, the total number of shares in Cavotec amounted to 94’243’200. Cavotec holds a total number of 0 shares as treasury shares. The total number of votes in Cavotec amounts to 94’243’200, of which Cavotec holds 0 votes. For information on how your personal data is processed, see the integrity policy that is available athttps://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf Frequently Asked Questions Q1: I want to vote at the meeting of shareholders of Cavotec SA. Do I have to appoint a proxy or register to attend the Meeting?A1: In consideration of the situation caused by the coronavirus, the personal attendance at the AGM 2021 is prohibited and shareholders can therefore exercise their rights exclusively through the Independent Proxy After having been registered (see below questions 3), you must appoint Mr. Franco Brusa, Attorney-at-law (the Independent Proxy), well in advance and in any case before May 21, 2021. Please note that you have to fill out the Proxy Form and send it to Mr. Franco Brusa, Attorney-at-law, c/o Euroclear Sweden AB, PO Box 191, SE-101 23 Stockholm, Sweden. Please note that you can also appoint Mr. Franco Brusa, Attorney-at-law electronically by using the Electronic Proxy according to the instructions set out on https://anmalan.vpc.se/Cavotec2021. Q2: May I directly register for voting rights with Cavotec SA or send the Proxy Form to Cavotec SA or to Mr. Franco Brusa?A2: Unfortunately, neither Cavotec SA nor Mr. Franco Brusa are able to process Proxy Forms sent to them. Please contact Euroclear Sweden AB, telephone: +46 8 402 92 83 for more information. If you hold your shares through SIX SIS AG (see question 3 below) and need further assistance with questions related to registering your share in the share register of Cavotec SA, please contact your custodian bank or Computershare Schweiz AG, telephone: +41 62 205 7700. The following questions 3-5 are only relevant, if you have not already registered your shares for the AGM. Q3: What do I have to do if I do not know whether I hold my Cavotec shares through SIX SIS AG or Euroclear Sweden AB or to which category of shareholders (i.e. Nominee-registered Holders or direct-registered holders) I belong?A3: Your custodian bank should be able to provide you with the required information. However, you may also contact Euroclear Sweden AB, e-mail: email@example.com, telephone: +46 8 402 92 83 or Computershare Schweiz AG, e-mail: firstname.lastname@example.org, telephone: +41 62 205 7700 for further information. To register your shares, please follow the instructions set out above for the corresponding category of shareholders. Q4: Who should I contact if I do not receive the necessary information/documents in connection with the AGM?A4: Please contact Euroclear Sweden AB (telephone: +46 8 402 92 83). Q5: When does the registration process for voting rights for shareholders who hold Cavotec Shares held through Euroclear Sweden AB via a nominee take place?A5: The registration in the Register of Shareholders starts on April 29, 2021, 21 calendar days prior to the Record Date, and ends at the end of the business day on May 20, 2021 For questions regarding participation in the AGM, please contact:Cavotec SAc/o Euroclear Sweden AB Box 191SE-10123 Stockholm, Sweden Telephone: +46 84029283 Lugano, April 21, 2021 For the Board of Directors of Cavotec SA Patrik TigerschiöldChairman For further details please contact: Johan Hähnel Investor Relations ManagerTelephone: +46 70 605 63 34Email: email@example.com The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on 21 April 2021. Attachment Notice of AGM 2021
Royal Vopak: Interim Update Q1 2021 In EUR millionsQ1 2020Q4 2019Q1 2019Revenues300.1303.7296.9 Results -excluding exceptional items- Group operating profit before depreciation and amortization (EBITDA)200.4188.8200.2Group operating profit (EBIT)121.3108.6127.0Net profit attributable to holders of ordinary shares73.156.882.7Earnings per ordinary share (in EUR)0.580.460.65 Results -including exceptional items- Group operating profit before depreciation and amortization (EBITDA)200.4159.8198.5Group operating profit (EBIT)121.379.6125.3Net profit attributable to holders of ordinary shares73.124.081.0Earnings per ordinary share (in EUR)0.580.200.64 Cash flows from operating activities (gross)124.0268.8142.7Cash flows from investing activities (including derivatives)-138.6-317.529.8 Additional performance measures Proportional EBITDA -excluding exceptional items-245.6244.4241.0Proportional occupancy rate 89%91%86%Storage capacity end of period (in million cbm)35.735.634.3Occupancy rate subsidiaries88%90%84% Return on capital employed (ROCE)10.3%11.0%11.5%Average capital employed4,478.34,184.04,252.0Net interest-bearing debt2,723.62,589.42,321.9Senior net debt : EBITDA (for debt covenant)2.602.522.65 Highlights for Q1 2021 -excluding exceptional items-: EBITDA of EUR 200 million (Q1 2020: EUR 200 million). Adjusted for negative currency translation effects, EBITDA grew by EUR 10 million (5%) reflecting new contributions from growth projects and negative impact from tight chemical markets as a result of amongst others the Texas winter storm. Proportional occupancy rate of 89% (Q1 2020: 86%) reflected improved demand compared to the same period last year. Cost efficiency measures are tracking well and the cost level for Q1 2021 amounted to EUR 149 million (Q1 2020: EUR 153 million) including cost for new growth projects and business development efforts. EBIT of EUR 121 million (Q1 2020: EUR 127 million). Return on capital employed (ROCE) of 10.3% (Q1 2020: 11.5%). Net profit attributable to holders of ordinary shares of EUR 73 million (Q1 2020: EUR 83 million), resulting in earnings per ordinary share (EPS) of EUR 0.58 (Q1 2020: EUR 0.65). Vopak’s senior net debt to EBITDA ratio is 2.60 at the end of Q1 2021, within the target range. Portfolio items: At the end of the first quarter of 2021, Vopak started operations of the Vopak Moda Houston terminal (US Gulf Coast) and initial capacity expansions were delivered in Mexico and the Netherlands. In the second quarter of 2021, the greenfield industrial terminal in Qinzhou, China, with an initial capacity of 290,000 cbm is expected to start operations. After ten years of continuous, safe and successful LNG operations, Gate terminal in Rotterdam, the Netherlands, will start its major maintenance turnaround to ensure the best in class service for its customers. The maintenance work is scheduled to last for approximately 1 month starting 15 June 2021. Exceptional items Q1 2021: There were no exceptional items in Q1 2021. Subsequent events: On 21 April 2021, Vopak announced that it signed a Joint Development Agreement with Elestor for the development of a hydrogen bromine flow battery. The joint ambition is to scale up the electricity storage capacity of these flow batteries from 200 kWh to 3,000 kWh in a period of 2 years and then further develop it to industrial scale. This development is part of Vopak’s New Energy strategy. Looking ahead: In 2021, EBITDA contributions from 2020 and 2021 growth projects are expected to be at the higher end of the EUR 30 million to EUR 50 million range, subject to market conditions and currency exchange movements. Cost management continues and we expect to manage the 2021 cost base including additional cost for new growth projects to be managed below EUR 615 million, subject to currency exchange movements. Vopak has the ambition to allocate some EUR 300 million to EUR 350 million to growth investments in 2021 through existing committed projects, new business development and pre-FID feasibility studies in new energies including hydrogen. The majority of growth investments will be allocated towards industrial, gas and new energies infrastructures. Our positive views on chemicals have not changed. New growth investments in oil infrastructure are expected to be reduced and will mostly be targeted towards strengthening our leading hub positions. For 2021 and beyond, we will keep storing vital products with care to make a meaningful contribution to society, enabled by our financial performance. The analysts’ presentation will be given via an on-demand audio webcast on Vopak’s corporate website, starting at 8:45 AM CEST on 21 April 2021. For more information please contact:Vopak Press: Liesbeth Lans - Manager External Communication,Telephone: +31 (0)10 400 2777 | e-mail: firstname.lastname@example.org Vopak Analysts and Investors: Laurens de Graaf - Head of Investor Relations, Telephone: +31 (0)10 400 2776 | e-mail: email@example.com About Royal VopakRoyal Vopak is the world’s leading independent tank storage company. We store vital products with care. With over 400 years of history and a focus on sustainability, we ensure safe, clean and efficient storage and handling of bulk liquid products and gases for our customers. By doing so, we enable the delivery of products that are vital to our economy and daily lives, ranging from chemicals, oils, gases and LNG to biofuels and vegoils. We are determined to develop key infrastructure solutions for the world’s changing energy and feedstock systems, while simultaneously investing in digitalization and innovation. Vopak is listed on the Euronext Amsterdam and is headquartered in Rotterdam, the Netherlands. For more information, please visit vopak.com. This press release contains inside information as meant in clause 7 of the Market Abuse Regulation. The content of this report has not been audited or reviewed by an external auditor.
ASML reports €4.4 billion net sales and €1.3 billion net income in Q1 2021 Strong demand across markets drives expected sales growth towards 30% in 2021 VELDHOVEN, the Netherlands, April 21, 2021 – today ASML Holding NV (ASML) has published its 2021 first-quarter results. Q1 net sales of €4.4 billion, gross margin of 53.9%, net income of €1.3 billionQ1 net bookings of €4.7 billionASML expects Q2 2021 net sales between €4.0 billion and €4.1 billion and a gross margin around 49% (Figures in millions of euros unless otherwise indicated) Q4 2020 Q1 2021 Net sales 4,254 4,364 ...of which Installed Base Management sales 1 1,056 1,235 New lithography systems sold (units) 73 73 Used lithography systems sold (units) 7 3 Net bookings 2 4,238 4,740 Gross profit 2,212 2,352 Gross margin (%) 52.0 53.9 Net income 1,351 1,331 EPS (basic; in euros) 3.23 3.21 End-quarter cash and cash equivalents and short-term investments 7,351 4,656 (1) Installed Base Management sales equals our net service and field option sales. (2) Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems). Numbers have been rounded for readers' convenience. A complete summary of US GAAP Consolidated Statements of Operations is published on www.asml.com CEO statement and outlook"Our first-quarter sales came in at €4.4 billion, which is above our guidance. The gross margin came in at 53.9%, also well above our guidance. The primary driver for higher revenue and gross margin was the increased Installed Base business. Due to the current high-demand environment, customers are utilizing software upgrades to increase capacity as quickly as possible. Our first-quarter net bookings came in at €4.7 billion, including €2.3 billion from EUV systems. "Compared to three months ago, we are seeing a significant increase in demand across all market segments and our product portfolio. The build-up of the digital infrastructure with secular growth drivers such as 5G, AI and High-Performance Computing solutions fuels demand for advanced and mature nodes in Logic as well as Memory. We now expect revenue growth towards 30% in 2021 compared to last year," said ASML President and Chief Executive Officer Peter Wennink. ASML expects second-quarter revenue between €4.0 billion and €4.1 billion with a gross margin around 49%, R&D costs of €650 million and SG&A costs of €175 million. The estimated annualized effective tax rate is expected to be between 14% and 15% for 2021. Products and business highlights In our EUV business, we improved transmission of the pellicle to 90%, supporting higher output in high-volume manufacturing of our customers.In our DUV business, we achieved over 300 wafers per hour at ASML on a TWINSCAN NXT:1470. This is almost a 50% improvement versus the previous model (XT:1460). We completed the 100th DUV SNEP (System Node Extension Package) upgrade at a customer. The SNEP product offers customers a low-cost solution elevating system performance to align with our more advanced technologies, thereby extending the lifetime of the system. We achieved the milestone of the 1000th shipment of a TWINSCAN KrF system. In our Applications business, as demand for scanners continues to increase in both EUV and DUV, we expect demand for scanner control applications to grow in 2021 as well. The newly released YieldStar 385 is beginning to ramp up across our customer base. Share buyback program updateAs part of its financial policy to return excess cash to its shareholders through growing dividends and share buybacks, in January 2020, ASML announced a three-year share buyback program, to be executed within the 2020–2022 time frame. As part of this program, ASML intends to purchase shares up to €6 billion, which includes a total of up to 0.4 million shares to cover employee share plans. ASML intends to cancel the remainder of the shares repurchased. ASML purchased shares in Q1 for over €1.6 billion. The expected cash generation enables the opportunity for continuation of significant share buybacks in the coming quarters and therefore ASML expects an early completion of the current share buyback program. Media Relations contacts Investor Relations contacts Monique Mols +31 6 5284 4418 Skip Miller +1 480 235 0934 Sander Hofman +31 6 2381 0214 Marcel Kemp +31 40 268 6494 Brittney Wolff Zatezalo +1 408 483 3207 Peter Cheang +886 3 659 6771 Quarterly video interview, investor callWith this press release, ASML has published a video interview in which CEO Peter Wennink discusses the 2021 first-quarter results and outlook for 2021. This can be viewed on www.asml.com. An investor call for both investors and the media will be hosted by CEO Peter Wennink and CFO Roger Dassen on April 21, 2021 at 15:00 Central European Time / 09:00 US Eastern Time. Details can be found on our website. About ASMLASML is one of the world’s leading manufacturers of chip-making equipment. Our vision is a world in which semiconductor technology is everywhere and helps to tackle society’s toughest challenges. We contribute to this goal by creating products and services that let chipmakers define the patterns that integrated circuits are made of. We continuously raise the capabilities of our products, enabling our customers to increase the value and reduce the cost of chips. By helping to make chips cheaper and more powerful, we help to make semiconductor technology more attractive for a larger range of products and services, which in turn enables progress in fields such as healthcare, energy, mobility and entertainment. ASML is a multinational company with offices in more than 60 cities in 16 countries, headquartered in Veldhoven, the Netherlands. We employ more than 28,000 people on payroll and flexible contracts (expressed in full time equivalents). ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. More information about ASML, our products and technology, and career opportunities is available on www.asml.com. US GAAP Financial Reporting ASML's primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting principles generally accepted in the United States of America. Quarterly US GAAP consolidated statements of operations, consolidated statements of cash flows and consolidated balance sheets are available on www.asml.com. The consolidated balance sheets of ASML Holding N.V. as of April 4, 2021, the related consolidated statements of operations and consolidated statements of cash flows for the quarter and three months ended April 4, 2021 as presented in this press release are unaudited. Regulated informationThis press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. Forward Looking StatementsThis document contains statements that are forward-looking, including statements with respect to expected trends, including trends in end markets and technology industry and business environment trends, outlook and expected financial results for Q2 2021, including expected revenues, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate for 2021, expected growth in net sales in 2021, expectations on gross margin, R&D and SG&A for full year 2021, system bookings, expected increases in Logic and Memory demand and revenue, expected trends in IBM revenue, long term growth opportunity, revenue opportunity through 2025, future growth outlook towards 2025 and long term demand drivers, expected benefits and performance of new systems and applications, expanding end market applications driving semiconductor demand, the expectation that EUV will continue to enable Moore's law and drive long term value for ASML, expected trends in demand, expected increase in output capability, product roadmap, expected EUV tool productivity and expectations on shipments in 2022, statements with respect to plans regarding dividends, including the intention to continue to return significant amounts of cash to shareholders through a combination of share buybacks and growing annualized dividends, the amount of the final dividend for 2020 and statements with respect to the 2020-2022 share buyback program including the amount of shares intended to be repurchased under the program and that expected cash generation enables opportunity for continued significant buybacks and that ASML expects early completion of the buyback program. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions; product demand and semiconductor equipment industry capacity; worldwide demand and manufacturing capacity utilization for semiconductors; the impact of general economic conditions on consumer confidence and demand for our customers’ products; performance of our systems, the duration and continued or increased severity of the COVID-19 outbreak and measures taken to contain it and other risks related to the impact of COVID-19 on the global economy and financial markets, as well as on ASML and its customers and suppliers, including their operations, and other risks relating to COVID-19 and other factors that may impact ASML’s sales and gross margin, including customer demand (including demand in Logic and Memory and for our IBM services) and ASML’s ability to obtain supplies for its products, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, production capacity and our ability to increase capacity, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, production capacity for our systems including delays in system production; our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation; availability of raw materials, critical manufacturing equipment and qualified employees; trade environment; import/export and national security regulations and orders and their impact on us, changes in exchange and tax rates; available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Attachments Link to press release Link to consolidated financial statements